Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

NCT04178317

Conditions
Cancer, Chronic Lymphocytic Leukemia (CLL), Chronic Disease, Disease Attributes, +14 more
Locations
  • Inje University - Busan Paik Hospital /ID# 233882 Busan, Busan Gwang Yeogsi, South Korea
  • Pusan National University Hospital /ID# 216850 Busan, Busan Gwang Yeogsi, South Korea
  • Kyungpook National University Hospital /ID# 233884 Daegu, Daegu Gwang Yeogsi, South Korea
  • The catholic university of korea st. Paul's hospital /ID# 238907 Seoul, Gyeonggido, South Korea
View all 13 locations
View Trial Details
Completed

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

NCT03898128

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Irst Irccs Meldola (FC), FC, Italy
  • AUSL Romagna Ravenna, RA, Italy
  • Azienda ULSS2 Marca Trevigiana Treviso, TV, Italy
  • ULSS 3 Serenissima Mestre, Venezia, Italy
View Trial Details
Completed

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT05687032

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • NanFang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 16 locations
View Trial Details
Completed

Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT03391466

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Santa Monica, California, United States
View all 72 locations
View Trial Details
Completed

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

NCT05364424

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • Memorial Cancer Institute at Memorial West Pembroke Pines, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
View Trial Details

Related conditions